EP0737314A4 - Nouvelles utilisations de produits de recombinaison de recepteurs de gal4 - Google Patents
Nouvelles utilisations de produits de recombinaison de recepteurs de gal4Info
- Publication number
- EP0737314A4 EP0737314A4 EP95905946A EP95905946A EP0737314A4 EP 0737314 A4 EP0737314 A4 EP 0737314A4 EP 95905946 A EP95905946 A EP 95905946A EP 95905946 A EP95905946 A EP 95905946A EP 0737314 A4 EP0737314 A4 EP 0737314A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- gal4
- novel uses
- receptor constructs
- constructs
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96111192A EP0743520A3 (fr) | 1993-12-30 | 1994-12-29 | Utilisations nouvelles des structures de GAL4-récepteur |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US177740 | 1988-04-05 | ||
US17774093A | 1993-12-30 | 1993-12-30 | |
PCT/US1994/014426 WO1995018380A1 (fr) | 1993-12-30 | 1994-12-29 | Nouvelles utilisations de produits de recombinaison de recepteurs de gal4 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96111192A Division EP0743520A3 (fr) | 1993-12-30 | 1994-12-29 | Utilisations nouvelles des structures de GAL4-récepteur |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0737314A1 EP0737314A1 (fr) | 1996-10-16 |
EP0737314A4 true EP0737314A4 (fr) | 1999-11-03 |
Family
ID=22649809
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95905946A Ceased EP0737314A4 (fr) | 1993-12-30 | 1994-12-29 | Nouvelles utilisations de produits de recombinaison de recepteurs de gal4 |
EP96111192A Withdrawn EP0743520A3 (fr) | 1993-12-30 | 1994-12-29 | Utilisations nouvelles des structures de GAL4-récepteur |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96111192A Withdrawn EP0743520A3 (fr) | 1993-12-30 | 1994-12-29 | Utilisations nouvelles des structures de GAL4-récepteur |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP0737314A4 (fr) |
JP (2) | JPH09504111A (fr) |
AU (2) | AU1436695A (fr) |
CA (2) | CA2182908A1 (fr) |
WO (1) | WO1995018380A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018380A1 (fr) * | 1993-12-30 | 1995-07-06 | The Salk Institute For Biological Studies | Nouvelles utilisations de produits de recombinaison de recepteurs de gal4 |
US5989808A (en) * | 1994-06-14 | 1999-11-23 | American Cyanamid Company | Identification of compounds affecting specific interaction of peptide binding pairs |
US6770446B1 (en) | 1994-06-14 | 2004-08-03 | Wyeth | Cell systems having specific interaction of peptide binding pairs |
WO1997010813A1 (fr) | 1995-09-18 | 1997-03-27 | Ligand Pharmaceuticals Incorporated | Antagonistes de ppar gamma pour le traitement de l'obesite |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
EP0977892A1 (fr) | 1997-04-24 | 2000-02-09 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Procedes et compositions a utiliser dans la modulation de l'expression de genes de metalloproteinases matricielles |
KR20010014218A (ko) | 1997-06-27 | 2001-02-26 | 오노 야꾸힝 고교 가부시키가이샤 | 신규의 리포터 유전자 dna를 포함하는 플라스미드dna 및 그 용도 |
WO1999005292A1 (fr) * | 1997-07-22 | 1999-02-04 | Chugai Seiyaku Kabushiki Kaisha | Methode de criblage de genes utilisant les recepteurs nucleaires |
JP2003520758A (ja) | 1998-06-12 | 2003-07-08 | リガンド・ファーマシューティカルズ・インコーポレイテッド | 抗エストロゲン耐性乳癌のrxrモジュレーターを用いた処置 |
AU3725600A (en) * | 1999-03-02 | 2000-09-21 | Maxygen, Inc. | Surrogate orphan ligands for orphan receptors |
DK1248604T4 (da) | 2000-01-21 | 2012-05-21 | Novartis Ag | Kombinationer indeholdende dipeptidylpeptidase-IV-inhibitorer og antidiabetiske midler |
WO2002097099A1 (fr) * | 2001-05-29 | 2002-12-05 | Valentis, Inc. | Expression regulee de somatostatine |
US6696473B2 (en) | 2001-12-21 | 2004-02-24 | X-Ceptor Therapeutics, Inc. | Heterocyclic modulators of nuclear receptors |
EP1388352A1 (fr) | 2002-08-08 | 2004-02-11 | Laboratoires Fournier S.A. | Utilisation d'un agoniste de PPAR-alpha pour traiter l'obesité associée au traitement avec un agonist de PPAR-gamma dans des patients |
EP1544307A1 (fr) * | 2003-12-18 | 2005-06-22 | AXXAM S.r.l. | Recepteur chimerique LAC9 et ses utilisations |
BRPI0612287A8 (pt) | 2005-06-27 | 2019-01-22 | Exelixis Inc | composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear |
MY159522A (en) | 2005-09-14 | 2017-01-13 | Takeda Pharmaceuticals Co | Administration of dipeptidyl peptidase inhibitors |
WO2011041293A1 (fr) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Dérivés pyrazolo [1, 5a] pyrimidines comme inhibiteurs de kinase 1 régulatrice de signal d'apoptose |
RS53176B (en) | 2010-02-03 | 2014-06-30 | Takeda Pharmaceutical Company Limited | KINASE INHIBITORS 1 REGULATING SIGNALS IN APOPTOSIS |
WO2013037482A1 (fr) | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Agonistes du récepteur du farnésoïde x pour le traitement et la prévention du cancer |
US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992016546A1 (fr) * | 1991-03-19 | 1992-10-01 | The Salk Institute For Biological Studies | Compositions a element de reaction et dosages les utilisant |
WO1993006215A1 (fr) * | 1991-09-17 | 1993-04-01 | The Salk Institute For Biological Studies | Recepteurs de la superfamille des recepteurs d'hormones thyroidiennes/steroides |
WO1993023431A1 (fr) * | 1992-05-14 | 1993-11-25 | Baylor College Of Medicine | Recepteurs d'hormones steroides mutees, procede d'utilisation et commutateur moleculaire pour therapie genique |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018380A1 (fr) * | 1993-12-30 | 1995-07-06 | The Salk Institute For Biological Studies | Nouvelles utilisations de produits de recombinaison de recepteurs de gal4 |
-
1994
- 1994-12-29 WO PCT/US1994/014426 patent/WO1995018380A1/fr not_active Application Discontinuation
- 1994-12-29 CA CA002182908A patent/CA2182908A1/fr not_active Abandoned
- 1994-12-29 CA CA 2180271 patent/CA2180271A1/fr not_active Abandoned
- 1994-12-29 EP EP95905946A patent/EP0737314A4/fr not_active Ceased
- 1994-12-29 AU AU14366/95A patent/AU1436695A/en not_active Abandoned
- 1994-12-29 JP JP7518075A patent/JPH09504111A/ja active Pending
- 1994-12-29 EP EP96111192A patent/EP0743520A3/fr not_active Withdrawn
-
1996
- 1996-07-04 AU AU58374/96A patent/AU700646B2/en not_active Ceased
- 1996-08-19 JP JP8217281A patent/JPH09275988A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992016546A1 (fr) * | 1991-03-19 | 1992-10-01 | The Salk Institute For Biological Studies | Compositions a element de reaction et dosages les utilisant |
WO1993006215A1 (fr) * | 1991-09-17 | 1993-04-01 | The Salk Institute For Biological Studies | Recepteurs de la superfamille des recepteurs d'hormones thyroidiennes/steroides |
WO1993023431A1 (fr) * | 1992-05-14 | 1993-11-25 | Baylor College Of Medicine | Recepteurs d'hormones steroides mutees, procede d'utilisation et commutateur moleculaire pour therapie genique |
Non-Patent Citations (1)
Title |
---|
See also references of WO9518380A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP0743520A2 (fr) | 1996-11-20 |
AU5837496A (en) | 1996-10-03 |
CA2182908A1 (fr) | 1995-07-01 |
AU1436695A (en) | 1995-07-17 |
EP0737314A1 (fr) | 1996-10-16 |
AU700646B2 (en) | 1999-01-14 |
JPH09504111A (ja) | 1997-04-22 |
EP0743520A3 (fr) | 1999-11-10 |
WO1995018380A1 (fr) | 1995-07-06 |
CA2180271A1 (fr) | 1995-07-06 |
JPH09275988A (ja) | 1997-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9302275D0 (en) | Novel compounds | |
AP9400653A0 (en) | Novel compounds | |
EP0737314A4 (fr) | Nouvelles utilisations de produits de recombinaison de recepteurs de gal4 | |
HU9600805D0 (en) | Polyazacycloalkanes as dichelants | |
GB9306460D0 (en) | Novel compounds | |
GB9306183D0 (en) | Novel compounds | |
GB9310485D0 (en) | Novel compounds | |
GB9308963D0 (en) | Novel compounds | |
GB9303825D0 (en) | Novel compounds | |
ZA94961B (en) | 15-oxasterols as hypocholesterolemics | |
GB9308178D0 (en) | Novel compounds | |
GB9306182D0 (en) | Novel compounds | |
GB9306235D0 (en) | Novel compounds | |
ZA949322B (en) | Novel substituted thiosemicarbazonethiones | |
GB9307694D0 (en) | Novel compounds | |
ZA935901B (en) | Novel amidoalkyl- and imodoalkyl-piperazines | |
EP0731803A4 (fr) | Nouvelles furanodiazepines | |
GB9307477D0 (en) | Novel compounds | |
GB9302272D0 (en) | Novel compounds | |
GB9306461D0 (en) | Novel compounds | |
GB9301980D0 (en) | Novel compounds | |
GB9304414D0 (en) | Novel compounds | |
GB9308969D0 (en) | Novel compounds | |
GB9303617D0 (en) | Novel compounds | |
GB9303607D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19960508 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
XX | Miscellaneous (additional remarks) |
Free format text: TEILANMELDUNG 96111192.9 EINGEREICHT AM 11/07/96. |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19990920 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20000308 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20040113 |